Rohan McLachlan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rohan McLachlan has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Richard John Harvey
Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research University of New South Wales Sydney Australia
3 shared publications Kornkiat Snidvongs
2 shared publicationsPeter Earls
Department of Anatomical Pathology St Vincent's Hospital Sydney Australia
2 shared publicationsRaymond Sacks
Australian School of Advanced Medicine Macquarie University Sydney Australia
2 shared publicationsSamiul Islam
Department of Vascular Surgery, Royal Prince Alfred Hospital, Sydney, Australia
2 shared publicationsAndrew F. Lennox
Department of Vascular Surgery, Prince of Wales Hospital, Sydney, New South Wales, Australia
1 shared publication
Latest Publications
- 1 October 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 76, 601.e13-601.e16
Open Thrombectomy for Acute Abdominal Aortic Occlusion Due to Tumor Embolism after Lung Resection
- 1 October 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 76, 601.e13-601.e16
Open Thrombectomy for Acute Abdominal Aortic Occlusion Due to Tumor Embolism after Lung Resection
- 1 November 2020
- Published by Wiley in Anz Journal of Surgery
- Vol. 90 (11) , 2374-2376
Aortoduodenal fistula 2 years after elective endovascular repair of an abdominal aortic aneurysm
- 1 November 2020
- Published by Wiley in Anz Journal of Surgery
- Vol. 90 (11) , 2374-2376
Aortoduodenal fistula 2 years after elective endovascular repair of an abdominal aortic aneurysm
- 1 July 2019
- Published by Elsevier in Journal of Surgical Education
- Vol. 76 (4) , 982-989
A Binational Need Assessment to Define the Level of Endovascular Expertise Required by Vascular Surgical Trainees
- 1 July 2019
- Published by Elsevier in Journal of Surgical Education
- Vol. 76 (4) , 982-989
A Binational Need Assessment to Define the Level of Endovascular Expertise Required by Vascular Surgical Trainees
- 1 April 2019
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 10 (2) , 235-243
The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
Background: Determine the effect of intraoperative fluids (IOFs) administered during cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) on postoperative patient outcomes. Methods: Retrospective cohort study of patients that underwent CRS/HIPEC from February 2010 to June 2017. Results: A total of 335 patients formed the cohort study. Patients who received higher IOFs had longer hospital length of stay (LOS) (34 vs. 22.5 days; Pvs. 3.2 days; Pvs. 23 days; Pvs. 3.4 days; Pvs. 25.2 days; P=0.04) and longer ICU admission (4.7 vs. 3.6 days; P=0.03). On multivariable analysis, less blood product transfusions demonstrated a decreased LOS in hospital by 4.8 days (P=0.01) and fewer grade 3/4 complications (OR 0.59; 95% CI, 0.35–0.99; P=0.05). Conclusions: Greater IOF administration is associated with an increase in postoperative morbidity, including hospital LOS, ICU admission and grade 3/4 complications, in patients undergoing CRS/HIPEC.
- 1 April 2019
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 10 (2) , 235-243
The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
Background: Determine the effect of intraoperative fluids (IOFs) administered during cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) on postoperative patient outcomes. Methods: Retrospective cohort study of patients that underwent CRS/HIPEC from February 2010 to June 2017. Results: A total of 335 patients formed the cohort study. Patients who received higher IOFs had longer hospital length of stay (LOS) (34 vs. 22.5 days; Pvs. 3.2 days; Pvs. 23 days; Pvs. 3.4 days; Pvs. 25.2 days; P=0.04) and longer ICU admission (4.7 vs. 3.6 days; P=0.03). On multivariable analysis, less blood product transfusions demonstrated a decreased LOS in hospital by 4.8 days (P=0.01) and fewer grade 3/4 complications (OR 0.59; 95% CI, 0.35–0.99; P=0.05). Conclusions: Greater IOF administration is associated with an increase in postoperative morbidity, including hospital LOS, ICU admission and grade 3/4 complications, in patients undergoing CRS/HIPEC.
- Open Access
- 1 March 2019
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 5 (1) , 31-34
Endovascular treatment of critical lower limb ischemia caused by giant cell arteritis
- 1 March 2019
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 5 (1) , 31-34
Open AccessEndovascular treatment of critical lower limb ischemia caused by giant cell arteritis
- 1 April 2013
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 20 (4) , 587-592
A cadaveric study of the endoscopic endonasal transclival approach to the basilar artery
- 1 April 2013
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 20 (4) , 587-592
A cadaveric study of the endoscopic endonasal transclival approach to the basilar artery
- 7 November 2012
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 3 (5) , 369-375
Correlation of the Kennedy Osteitis Score to clinico‐histologic features of chronic rhinosinusitis
Background: Osteitis is a feature of chronic rhinosinusitis (CRS) and often associated with recalcitrant disease. Radiological characteristics of osteitic sinus changes are commonly reported in practice but the clinical and pathologic significance is poorly defined. The objective of this study was to correlate the Kennedy Osteitis Score (KOS) to clinico‐histologic features of CRS.Methods: A cross‐sectional study of CRS patients undergoing sinus surgery was conducted. Osteitis was scored radiologically using the KOS. Associations between osteitis and histopathology, symptoms, 22‐item Sino‐Nasal Outcomes Test (SNOT‐22), endoscopy, computed tomography (CT) mucosal score, and seromarkers were assessed. Interobserver correlation coefficient was performed. Additionally, the KOS was correlated to an alternate Global Osteitis Score.Results: A total of 88 patients were assessed (45.5% female, age 50.3 ± 13.6 years); 45 (51.1%) patients had osteitis. Patients with KOS >0, had greater endoscopy score (6.1 ± 2.9 vs 4.4 ± 3.6, p = 0.03) and CT score (14.0 ± 6.0 vs 10.1 ± 5.7, p < 0.01) than those without osteitis. There was no difference in symptom score (2.4 ± 1.3 vs 2.4 ± 1.1, p = 0.89) and SNOT‐22 (2.0 ± 1.0 vs 1.9 ± 1.1, p = 0.56) in patients with and without osteitis. KOS was higher in patients with tissue eosinophilia >10/high‐power field (HPF) (median 3.0 [IQR, 1.0–5.3] vs 0.0 [0.0–4.0], p = 0.03) and serum eosinophilia >0.3 × 109/L (4.0 [2.0–7.0] vs 1.0 [0.0–4.0], p < 0.01). Importantly, this was also true for those without prior surgery. The interobserver correlation coefficient was good (R = 0.86, p < 0.001). There was a significant correlation between the KOS and the Global Osteitis Score (R = 0.93, p < 0.001).Conclusion: The KOS is a simple, easy, and reproducible scale in assessing osteitic bones in patients with CRS and can predict measures of severity in eosinophilic rhinosinusitis.
- 7 November 2012
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 3 (5) , 369-375
Correlation of the Kennedy Osteitis Score to clinico‐histologic features of chronic rhinosinusitis
Background: Osteitis is a feature of chronic rhinosinusitis (CRS) and often associated with recalcitrant disease. Radiological characteristics of osteitic sinus changes are commonly reported in practice but the clinical and pathologic significance is poorly defined. The objective of this study was to correlate the Kennedy Osteitis Score (KOS) to clinico‐histologic features of CRS.Methods: A cross‐sectional study of CRS patients undergoing sinus surgery was conducted. Osteitis was scored radiologically using the KOS. Associations between osteitis and histopathology, symptoms, 22‐item Sino‐Nasal Outcomes Test (SNOT‐22), endoscopy, computed tomography (CT) mucosal score, and seromarkers were assessed. Interobserver correlation coefficient was performed. Additionally, the KOS was correlated to an alternate Global Osteitis Score.Results: A total of 88 patients were assessed (45.5% female, age 50.3 ± 13.6 years); 45 (51.1%) patients had osteitis. Patients with KOS >0, had greater endoscopy score (6.1 ± 2.9 vs 4.4 ± 3.6, p = 0.03) and CT score (14.0 ± 6.0 vs 10.1 ± 5.7, p < 0.01) than those without osteitis. There was no difference in symptom score (2.4 ± 1.3 vs 2.4 ± 1.1, p = 0.89) and SNOT‐22 (2.0 ± 1.0 vs 1.9 ± 1.1, p = 0.56) in patients with and without osteitis. KOS was higher in patients with tissue eosinophilia >10/high‐power field (HPF) (median 3.0 [IQR, 1.0–5.3] vs 0.0 [0.0–4.0], p = 0.03) and serum eosinophilia >0.3 × 109/L (4.0 [2.0–7.0] vs 1.0 [0.0–4.0], p < 0.01). Importantly, this was also true for those without prior surgery. The interobserver correlation coefficient was good (R = 0.86, p < 0.001). There was a significant correlation between the KOS and the Global Osteitis Score (R = 0.93, p < 0.001).Conclusion: The KOS is a simple, easy, and reproducible scale in assessing osteitic bones in patients with CRS and can predict measures of severity in eosinophilic rhinosinusitis.
- 4 October 2012
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 3 (2) , 121-128
Clinical severity and epithelial endotypes in chronic rhinosinusitis
Background: Chronic rhinosinusitis (CRS) is a heterogeneous disease defined by epithelial inflammation. The link between measures of traditional disease severity and markers of epithelial inflammation is poorly understood as prior research has focused on presence of polyps or degree of eosinophilia. The expression of 3 epithelial derived cytokines implicated in initiation of T‐helper 2 (Th2) inflammation and an eosinophil chemoattractant were compared with clinical measures used in CRS.Methods: Sinus mucosal samples from CRS patients undergoing sinus surgery were analyzed for interleukin‐25 (IL‐25), IL‐33, thymic stromal lymphopoietin (TSLP), and eotaxin‐3 messenger RNA (mRNA) expression by quantitative polymerase chain reaction (PCR). Tumor patients undergoing surgery transnasally with normal sinus mucosa were controls. Gene expression was compared with symptom, radiology, and endoscopy scores, serological markers, presence of reactive airways disease (RAD), and atopy.Results: Thirty‐seven patients (38% female, mean age 48 ± 15 years), 12 CRS with nasal polyps (CRSwNP), 18 CRS without nasal polyps (CRSsNP), and 7 controls were recruited. CRSwNP phenotype predicted elevated IL‐25, IL‐33, and eotaxin‐3 levels. Increased eotaxin‐3 correlated with poorer computed tomography (CT) (p = 0.004) and endoscopic scores (p = 0.049). Increased IL‐25 correlated with poorer CT scores (p = 0.012) and raised serum eosinophils (p = 0.006). No associations with RAD, atopy, and symptom measures were found. No associations for IL‐33 and TSLP were found.Conclusion: Inflammatory mediators of the epithelium in CRS has some correlation with traditional measures of disease burden. Certain epithelial profiles may predict highly dysfunctional epithelial barriers and prospective evaluation of the clinical outcomes from interventions is required. Future endotyping of the epithelium in CRS may be able to provide prognostic information.
- 4 October 2012
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 3 (2) , 121-128
Clinical severity and epithelial endotypes in chronic rhinosinusitis
Background: Chronic rhinosinusitis (CRS) is a heterogeneous disease defined by epithelial inflammation. The link between measures of traditional disease severity and markers of epithelial inflammation is poorly understood as prior research has focused on presence of polyps or degree of eosinophilia. The expression of 3 epithelial derived cytokines implicated in initiation of T‐helper 2 (Th2) inflammation and an eosinophil chemoattractant were compared with clinical measures used in CRS.Methods: Sinus mucosal samples from CRS patients undergoing sinus surgery were analyzed for interleukin‐25 (IL‐25), IL‐33, thymic stromal lymphopoietin (TSLP), and eotaxin‐3 messenger RNA (mRNA) expression by quantitative polymerase chain reaction (PCR). Tumor patients undergoing surgery transnasally with normal sinus mucosa were controls. Gene expression was compared with symptom, radiology, and endoscopy scores, serological markers, presence of reactive airways disease (RAD), and atopy.Results: Thirty‐seven patients (38% female, mean age 48 ± 15 years), 12 CRS with nasal polyps (CRSwNP), 18 CRS without nasal polyps (CRSsNP), and 7 controls were recruited. CRSwNP phenotype predicted elevated IL‐25, IL‐33, and eotaxin‐3 levels. Increased eotaxin‐3 correlated with poorer computed tomography (CT) (p = 0.004) and endoscopic scores (p = 0.049). Increased IL‐25 correlated with poorer CT scores (p = 0.012) and raised serum eosinophils (p = 0.006). No associations with RAD, atopy, and symptom measures were found. No associations for IL‐33 and TSLP were found.Conclusion: Inflammatory mediators of the epithelium in CRS has some correlation with traditional measures of disease burden. Certain epithelial profiles may predict highly dysfunctional epithelial barriers and prospective evaluation of the clinical outcomes from interventions is required. Future endotyping of the epithelium in CRS may be able to provide prognostic information.
- 1 January 2012
- Published by Stichting Nase in Rhinology journal
- Vol. 50 (3) , 299-305
Osteitic bone: a surrogate marker of eosinophilia in chronic rhinosinusitis
- 1 January 2012
- Published by Stichting Nase in Rhinology journal
- Vol. 50 (3) , 299-305
Osteitic bone: a surrogate marker of eosinophilia in chronic rhinosinusitis